Stocktoria
JOHNSON & JOHNSON JNJ
JOHNSON & JOHNSON financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94.2B | $88.8B | $85.2B | $80.0B | $78.7B | $82.6B | $82.1B | $81.6B | $76.5B | $71.9B |
| Gross profit | $63.9B | $61.4B | $58.6B | $55.4B | $55.3B | $54.2B | $54.5B | $54.5B | $51.0B | $50.1B |
| R&D expense | $109.0M | $1.8B | $483.0M | $0 | $0 | — | — | — | — | — |
| SG&A expense | $23.7B | $22.9B | $21.5B | $20.2B | $20.1B | $22.1B | $22.2B | $22.5B | $21.5B | $20.1B |
| Interest expense | — | — | $772.0M | $276.0M | $183.0M | $201.0M | $318.0M | $1.0B | $934.0M | $726.0M |
| Income tax | $5.8B | $2.6B | $1.7B | $3.0B | $1.4B | $1.8B | $2.2B | $2.7B | $16.4B | $3.3B |
| Net income | $26.8B | $14.1B | $35.2B | $17.9B | $20.9B | $14.7B | $15.1B | $15.3B | $1.3B | $16.5B |
| EPS (diluted) | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 | $5.51 | $5.63 | $5.61 | $0.47 | $5.93 |
| Operating cash flow | $24.5B | $24.3B | $22.8B | $21.2B | $23.4B | $23.5B | $23.4B | $22.2B | $21.1B | $18.8B |
| Free cash flow | $19.7B | $19.8B | $18.2B | $17.2B | $19.8B | $20.2B | $19.9B | $18.5B | $17.8B | $15.5B |
| Cash & equivalents | $19.7B | $24.1B | $21.9B | $12.9B | $14.5B | $14.0B | $17.3B | $18.1B | $17.8B | $19.0B |
| Inventory | $14.2B | $12.4B | $11.2B | $10.3B | $10.4B | $9.3B | $9.0B | $8.6B | $8.8B | $8.1B |
| Total assets | $199.2B | $180.1B | $167.6B | $187.4B | $182.0B | $174.9B | $157.7B | $153.0B | $157.3B | $141.2B |
| Total liabilities | $117.7B | $108.6B | $98.8B | $110.6B | $108.0B | $111.6B | $98.3B | $93.2B | $97.1B | $70.8B |
| Shareholders' equity | $81.5B | $71.5B | $68.8B | $76.8B | $74.0B | $63.3B | $59.5B | $59.8B | $60.2B | $70.4B |
Growth · year-over-year · Revenue CAGR 3%
| Metric | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +6.0% | +4.3% | +6.5% | +1.6% | -4.7% | +0.6% | +0.6% | +6.7% | +6.3% | — |
| Net income growth | +90.6% | -60.0% | +95.9% | -14.1% | +41.9% | -2.7% | -1.2% | +1076.7% | -92.1% | +7.3% |
| EPS growth | +90.5% | -57.8% | +103.9% | -13.8% | +41.7% | -2.1% | +0.4% | +1093.6% | -92.1% | +8.2% |
| Free cash flow growth | -0.7% | +8.7% | +6.2% | -13.0% | -2.1% | +1.4% | +7.5% | +4.2% | +14.4% | -3.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-28. Facts plus Stocktoria's own computed scores — not investment advice.